Role of inflammation and immune response in atherosclerosis: Mechanisms, modulations, and therapeutic targets

Hum Immunol. 2023 Jun 21:S0198-8859(23)00086-1. doi: 10.1016/j.humimm.2023.06.002. Online ahead of print.ABSTRACTCardiovascular diseases (CVDs) have emerged as the leading cause of mortality globally, with atherosclerosis being a prominent focus of investigation among medical researchers worldwide. Atherosclerosis is characterized as a disease of the large and medium-sized arteries that is multifocal, accumulative, and immunoinflammatory in nature, resulting from the deposition of lipids. Accumulating evidence suggests that inflammatory responses and immunoregulation play a vital role in the occurrence and development of atherosclerosis. While existing treatments for atherosclerosis can assist in symptom management and slowing disease progression, a complete cure remains elusive. Consequently, there is significant interest in research and development of potential new drugs for this condition. Therefore, this review aims to consolidate the current understanding of the pathogenesis of atherosclerosis with an emphasis on inflammation, immune response and infection. Besides, it examines the effects and mechanisms of immunological modulations in atherosclerosis, and the potential therapeutic targets and drugs for intervening in the inflammatory responses and immunoregulation associated with atherosclerosis. Additionally, novel drug options for treating atherosclerosis are explored within the context of this review.PMID:37353446 | DOI:10.1016/j.humimm.2023.06.002
Source: Human Immunology - Category: Allergy & Immunology Authors: Source Type: research